|Articles|July 1, 1998

July 1998
Volume 4
Issue 7

Treatment Options for Prostate Cancer: Part 1--Stage, Grade, PSA, and Changes in the 1990's

Author(s)LTC Judd W. Moul, MD, MC, USA

Download PDF: Treatment Options for Prostate Cancer: Part 1--Stage, Grade, PSA, and Changes in the 1990's

Articles in this issue

over 27 years ago

Article

A New Method of Developing Expert Consensus Practice Guidelines

over 27 years ago

Article

Patient Consultation in a Managed Care Setting: Guiding Pharmacy into the Future

over 27 years ago

Article

Should Clinicians Rely on Expert Opinion or Empirical Findings?

over 27 years ago

Article

Compliance with Anti-Hypertensive Therapy: Raising the Bar of Expectations

over 27 years ago

Article

In Vitro and Skin Testing for Allergy: Comparable Clinical Utility and Costs

over 27 years ago

Article

Impact of Pharmacist Consultations Provided to Patients with Diabetes on Healthcare Costs in a Health Maintenance Organization

over 27 years ago

Article

The Cost-Effectiveness of Treatment with Lamivudine and Zidovudine Compared with Zidovudine Alone: A Comparison of Markov Model and Trial Data Estimates

over 27 years ago

Article

Introducing Managed Care to the Medical School Curriculum: Effect on Student Attitudes

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

ByNate C. Apathy, PhD

January 27th 2026

Building Trust: Public Priorities for Health Care AI Labeling

ByMorgan L. Sielaff, BS,Jodyn Platt, PhD, MPH,Sean Tan, MPP,Kerry A. Ryan, MA,Paige Nong, PhD,Sharon L. R. Kardia, PhD

January 27th 2026

Ambient AI Tool Adoption in US Hospitals and Associated Factors

ByFreddie Yang, MA,Ilana Graetz, PhD

January 27th 2026

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Treatment Options for Prostate Cancer: Part 1--Stage, Grade, PSA, and Changes in the 1990's

Articles in this issue

Newsletter

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Specialty and Operator Status Influence Electronic Health Record Use Variation

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

PBM Reforms Signed Into Law, Reshaping Medicare Part D Drug Pricing Transparency

FDA Flags Administration Concerns for Aquestive's Noninvasive Epinephrine Film

Telomere Length and Polygenic Risk Shape Endotypes in Idiopathic Pulmonary Fibrosis

Is Rare Disease Policy a Stress Test of US Health Care?

From Biologics to Bio-Machines: Top Takeaways From Maui Derm 2026